Recursion Pharmaceuticals Inc. (RXRX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Recursion Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$4.35
+7.41% today
Market cap
$2.4B
Overall quality
—
Kronos AI 30-day
−23.3%
1 of 8 simulated paths end higher
Recursion Pharmaceuticals Inc. (RXRX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $2.4B. It trades at $4.35, up 7.41% today. 5 analysts' average target of $6.63 implies +52.4% from today's price. Kronos AI's 30-day forecast is −23.3% (1 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $6.63 |
| Low – high | $5.90 – $8.00 |
| Analysts | 5 |
| Upside to average | +52.4% |
Kronos AI 30-day forecast
| Expected close | $3.11 (−23.3%) |
| Likely range | −27.0% … −8.7% |
| As of | 2026-10-27 |
1 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.